CROCETTA, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.014
EU - Europa 597
AS - Asia 297
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
AF - Africa 1
Totale 1.915
Nazione #
US - Stati Uniti d'America 1.003
IT - Italia 135
IE - Irlanda 119
CN - Cina 116
SE - Svezia 114
SG - Singapore 114
GB - Regno Unito 55
UA - Ucraina 53
TR - Turchia 40
FR - Francia 31
DE - Germania 28
RU - Federazione Russa 20
VN - Vietnam 13
FI - Finlandia 12
ES - Italia 9
MX - Messico 8
IN - India 7
CZ - Repubblica Ceca 5
CH - Svizzera 4
EU - Europa 4
PL - Polonia 3
BD - Bangladesh 2
BE - Belgio 2
BG - Bulgaria 2
IR - Iran 2
RS - Serbia 2
TH - Thailandia 2
BR - Brasile 1
CA - Canada 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NL - Olanda 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
Totale 1.915
Città #
Chandler 269
Dublin 118
Jacksonville 108
Singapore 100
Ashburn 93
Chieti 62
Princeton 58
Southend 42
Dearborn 39
Ann Arbor 28
Beijing 27
Nanjing 26
Wilmington 26
Izmir 23
Santa Clara 22
Washington 18
Los Angeles 17
Dong Ket 13
Altamura 12
Cambridge 12
Nanchang 9
Jiaxing 8
Kunming 8
Varallo 8
Vittuone 7
Ciudad de Villa de Álvarez 6
Norwalk 6
Rome 6
Woodbridge 6
Bellaterra 5
Boardman 5
Monfalcone 5
Shenyang 5
Geneva 4
Sabadell 4
Tianjin 4
Changsha 3
Civitanova Marche 3
Edinburgh 3
Falls Church 3
Hefei 3
Jinan 3
Shanghai 3
Ankara 2
Bangkok 2
Belgrade 2
Brno 2
Brussels 2
Chicago 2
Ciudad de Villa de Alvarez 2
Delhi 2
Grevenbroich 2
Hebei 2
Helsinki 2
Lanzhou 2
Las Vegas 2
Milan 2
Molise 2
Napoli 2
New Delhi 2
Ningbo 2
Olomouc 2
Sofia 2
Warsaw 2
Amsterdam 1
Asunción 1
Augusta 1
Berlin 1
Chaoyang 1
Dallas 1
Florence 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Hanover 1
Harbin 1
Houston 1
Kuala Lumpur 1
Limana 1
London 1
Luxembourg 1
Manchester 1
Messina 1
Montreal 1
Oderzo 1
Orange 1
Orsogna 1
Panama City 1
Paris 1
Rzeszów 1
Saint Louis 1
San Juan 1
San Mateo 1
St Louis 1
São Paulo 1
Teramo 1
Trento 1
Udine 1
Villamagna 1
Weihai 1
Totale 1.308
Nome #
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 120
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 101
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 99
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 81
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 79
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 79
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 78
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 77
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 76
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 73
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 72
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 70
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 69
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 69
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 68
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 67
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 67
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 62
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 61
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 59
Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year infection in the lungs of a cystic fibrosis patient 56
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 55
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 54
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 54
Potential Novel Therapeutic Strategies in Cystic Fibrosis: Antimicrobial and Anti-Biofilm Activity of Natural and Designed Alpha-Helical Peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 49
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis biofilm-related lung infections caused by Pseudomonas aeruginosa. 48
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 47
The importance of postmortem microbiological examination for the ex post diagnosis of infection: fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus. 45
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis lung infection caused by Pseudomonas aeruginosa 43
In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis 40
Toward optimization of a BMAP-derived antimicrobial peptide for the treatment of pulmonary infections caused by Pseudomonas aeruginosa in cystic fibrosis patients. 36
A longitudinal population genomic study of Stenotrophomonas maltophilia in cystic fibrosis patients: expanding our knowledge about an emerging opportunistic pathogen. 17
Cyclization of acyl thiosemicarbazides led to new Helicobacter pylori α-carbonic anhydrase inhibitors 3
Totale 2.074
Categoria #
all - tutte 8.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020176 0 0 0 0 30 25 32 20 6 20 41 2
2020/2021196 22 10 53 8 15 33 2 4 7 15 7 20
2021/2022207 1 11 3 49 4 2 2 14 12 1 36 72
2022/2023586 47 85 54 77 40 106 24 43 75 5 23 7
2023/2024261 11 12 32 18 22 81 38 19 1 4 3 20
2024/2025251 23 111 82 23 12 0 0 0 0 0 0 0
Totale 2.074